(c) 2024 PillSync.com

pramipexole dihydrochloride extendedrelease pramipexole dihydrochloride tablet extended release

1 INDICATIONS AND USAGE Pramipexole dihydrochloride extended-release tablets are indicated for the treatment of Parkinson’s disease. Pramipexole dihydrochloride extended-release tablets are a non-ergot dopamine agonist indicated for the treatment of Parkinson’s disease (PD) ( 1 )

xiamen lp pharmaceutical co., ltd.


3 years ago ROUND WHITE 002 pramipexole dihydrochloride extendedrelease pramipexole dihydrochloride tablet extended release

ROUND WHITE 002

16 HOW SUPPLIED/STORAGE AND HANDLING 16.1 How Supplied

PRAMIPEXOLE DIHYDROCHLORIDE extended-release tablets are available as follows: 0.375 mg: white to off-white, round, convex shaped, extended-release tablets debossed with “002” on one side and plain on the other side. Unit of Use Bottles of 30 NDC 71034-002-30 0.75 mg: white to off-white, round, convex shaped, extended-release tablets debossed with “003” on one side and plain on the other side. Unit of Use Bottles of 30 NDC 71034-003-30 16.2 Storage and Handling Store at 25°C (77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. Protect from exposure to high humidity. Store in a safe place out of the reach of children.


More pills like ROUND 002












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site